John D. Bower

TL;DR: Adequate dialysis with special attention to proper nutrition aimed to achieve the high end of normal BMI may help to reduce the high mortality and morbidity in hemodialysis patients.

TL;DR: A modified, double-blinded, controlled trial examined the efficacy and safety of 1αD 2 use in 138 hemodialysis patients with moderate to severe secondary hyperparathyroidism by using novel dose titration, with acceptable mild hypercalcemia and hyperphosphatemia.

TL;DR: In intermittent oral and intravenous therapy with 1 alphaD(2) reduced iPTH levels effectively and similarly, hypercalcemia was less frequent, and serum phosphorus levels increased less during intravenous than oral 1alphaD( 2) therapy, suggesting that intravenous 1alphaCiferol therapy may be advantageous in patients prone to hyperCalcemia or hyperphosphatemia.

TL;DR: Folic acid improves cardiac remodeling and EE function by decreasing one of the D- or L-isomer of Hcy and by decreasing MMP activity in HHR, which may suggest a differential role of L- and D-isomers in vascular versus heart remodeling.

TL;DR: Three anephric patients were studied during sequential periods of normal hydration and overhydration, and long-term autoregulation of blood flow is suggested as an important factor in the observed sequence of events.